home *** CD-ROM | disk | FTP | other *** search
/ Libris Britannia 4 / science library(b).zip / science library(b) / MEDICAL / 1211.ZIP / 56 < prev    next >
Text File  |  1987-10-07  |  581b  |  16 lines
  1.  
  2.          IN PATIENTS WITH RENAL IMPAIRMENT, CLOFIBRATE DOSAGE SHOULD
  3.          BE CAREFULLY ADJUSTED TO AVOID TOXICITY (MYOSITIS,
  4.          ARTHRALGIA).
  5.           
  6.          SOME CLINICIANS RECOMMEND THAT THE DOSAGE REGIMEN BE
  7.          ADJUSTED BASED ON THE PATIENT'S CREATININE CLEARANCE:
  8.           
  9.                  CREATININE            DOSAGE INTERVAL
  10.                   CLEARANCE                 METHOD
  11.                  (ML/MINUTE)
  12.           
  13.                     10-50               12 to 18 hours
  14.                      <10                24 to 48 hours
  15.           
  16.